WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Earnings & Revenue

IONS past revenue growth

How has IONS's revenue growth performed historically?
Company
34.84%
Industry
89.94%
Market
19.39%
IONS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IONS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IONS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IONS earnings and revenue history

Current Revenue
$776.6M
Current Earnings
-$384.8M
Current Profit Margin
-49.5%

IONS Return on Equity

Current Company
-107.9%
Current Industry
16.8%
Current Market
28.2%
IONS's Return on Equity (-107.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IONS announces earnings.

IONS Return on Assets

Current Company
-13.2%
Current Industry
3.2%
IONS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IONS Return on Capital Employed

Current Company
-11.38%
Current Industry
-42.4%
IONS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IONS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IONS$776.62M-$254.76M-$384.77M+0.63%N/A
BPMC$282.21M-$246.69M-$288.29M+44.82%N/A
SMMT$0.00-$114.32M-$116.03M-100.00%N/A
HALO$862.99M$495.45M$318.80M+37.13%+101.37%
JAZZ$3.84B$1.16B$330.79M+14.48%-8.51%

IONS earnings dates

Next earnings date
Aug 1, 2024

Ionis Pharmaceuticals Earnings & Revenue FAQ

What were IONS's earnings last quarter?

On Invalid Date, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 2024 earnings per share (EPS) of -$0.98, up 12.64% year over year. Total Ionis Pharmaceuticals earnings for the quarter were -$142.80 million. In the same quarter last year, Ionis Pharmaceuticals's earnings per share (EPS) was -$0.87.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.

What was IONS's earnings growth in the past year?

As of Q3 2024, Ionis Pharmaceuticals's earnings has grown year over year. Ionis Pharmaceuticals's earnings in the past year totalled -$384.77 million.

What is IONS's earnings date?

Ionis Pharmaceuticals's earnings date is Invalid Date. Add IONS to your watchlist to be reminded of IONS's next earnings announcement.

What was IONS's revenue last quarter?

On Invalid Date, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 2024 revenue of $119.50 million up 8.45% year over year. In the same quarter last year, Ionis Pharmaceuticals's revenue was $130.52 million.

What was IONS's revenue growth in the past year?

As of Q3 2024, Ionis Pharmaceuticals's revenue has grown 34.84% year over year. This is 55.1 percentage points lower than the US Biotechnology industry revenue growth rate of 89.94%. Ionis Pharmaceuticals's revenue in the past year totalled $776.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.